Prevalence of Conventional Risk Factors in Jordanians with Coronary Heart Disease: the Jordan Hyperlipidemia and Related Targets Study (JoHARTS)
Overview
Authors
Affiliations
Background: The prevalence of the major conventional cardiovascular risk factors - cigarette smoking, diabetes mellitus, hypertension, and dyslipidemia - among coronary heart disease (CHD) patients in the Middle East has not been studied extensively.
Methods And Results: The Jordan Hyperlipidemia And Related Targets Study (JoHARTS) evaluated the prevalence of the 4 conventional risk factors in 5000 individuals including 1692 (34%) women. CHD was present in 1534 (31%) individuals (1202 men and 332 women). Among CHD patients, at least one risk factor was present in the majority of men (95%) and women (96%). Compared with women who had CHD, men had significantly higher prevalence of smoking (45% vs. 11%, p < 0.0001) and low levels of high-density lipoprotein cholesterol (60% vs. 39%, p < 0.0001), and lower prevalence of diabetes (40% vs. 64%, p < 0.0001), hypertension (38% vs. 63%, p < 0.0001), and hypercholesterolemia (19% vs. 27%, p = 0.003). Diabetes was more prevalent among men and women with CHD than men and women without CHD (40% vs. 18% for men, and 64% vs. 24% for women p < 0.0001). Similarly, smoking was more prevalent in men and women with CHD than those without CHD (45% vs. 32% for men, and 11% vs. 7%, p < 0.0001). Low levels of high-density lipoprotein cholesterol were also more prevalent in men with CHD than those without CHD (60% vs. 51%, p < 0.001) and among women with CHD than those without CHD (39% vs. 24%, p = 0.0001). Prevalence rates of hypertension, hypercholesterolemia, and hypertriglyceridemia were not different among individuals with or without CHD.
Conclusion: These results further challenge claims that patients with CHD commonly lack conventional risk factors. The great majority (>95%) of CHD patients studied have at least one risk factor. Detection, evaluation and management of these factors are essential steps to control CHD in the region.
Al-Shudifat A, Hammoudeh A, Al Saud W, Ibdah R, Araydah M, Zaqqa A Vasc Health Risk Manag. 2024; 20:313-322.
PMID: 39005236 PMC: 11244616. DOI: 10.2147/VHRM.S468209.
A Jordanian Multidisciplinary Consensus Statement on the Management of Dyslipidemia.
Al Mousa E, Al-Azzam S, Araydah M, Karasneh R, Ghnaimat M, Al-Makhamreh H J Clin Med. 2023; 12(13).
PMID: 37445345 PMC: 10342566. DOI: 10.3390/jcm12134312.
Dagamseh A, Qananwah Q, Al Quran H, Ibrahim K Biomed Opt Express. 2022; 12(12):7732-7751.
PMID: 35003863 PMC: 8713675. DOI: 10.1364/BOE.444535.
Obeidat O, Makhamreh H, Al-Muhaisen R, Obeidat L, Kitana F, Amarin J Heart Views. 2021; 22(2):88-95.
PMID: 34584618 PMC: 8445134. DOI: 10.4103/HEARTVIEWS.HEARTVIEWS_67_20.
Dugani S, Murad W, Damilig K, Atos J, Mohamed E, Callachan E Angiology. 2019; 71(1):17-26.
PMID: 31129986 PMC: 6878147. DOI: 10.1177/0003319719849737.